Literature DB >> 19407341

Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor.

Tatsuya Hoshino1, Takushi Namba, Masaya Takehara, Tadashi Nakaya, Yukihiko Sugimoto, Wataru Araki, Shuh Narumiya, Toshiharu Suzuki, Tohru Mizushima.   

Abstract

Amyloid-beta (Abeta) peptides, generated by the proteolysis of beta-amyloid precursor protein by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease. Inflammation is also important. We recently reported that prostaglandin E(2) (PGE(2)), a strong inducer of inflammation, stimulates the production of Abeta through EP(2) and EP(4) receptors, and here we have examined the molecular mechanism. Activation of EP(2) and EP(4) receptors is coupled to an increase in cellular cAMP levels and activation of protein kinase A (PKA). We found that inhibitors of adenylate cyclase and PKA suppress EP(2), but not EP(4), receptor-mediated stimulation of the Abeta production. In contrast, inhibitors of endocytosis suppressed EP(4), but not EP(2), receptor-mediated stimulation. Activation of gamma-secretase was observed with the activation of EP(4) receptors but not EP(2) receptors. PGE(2)-dependent internalization of the EP(4) receptor was observed, and cells expressing a mutant EP(4) receptor lacking the internalization activity did not exhibit PGE(2)-stimulated production of Abeta. A physical interaction between the EP(4) receptor and PS-1, a catalytic subunit of gamma-secretases, was revealed by immunoprecipitation assays. PGE(2)-induced internalization of PS-1 and co-localization of EP(4), PS-1, and Rab7 (a marker of late endosomes and lysosomes) was observed. Co-localization of PS-1 and Rab7 was also observed in the brain of wild-type mice but not of EP(4) receptor null mice. These results suggest that PGE(2)-stimulated production of Abeta involves EP(4) receptor-mediated endocytosis of PS-1 followed by activation of the gamma-secretase, as well as EP(2) receptor-dependent activation of adenylate cyclase and PKA, both of which are important in the inflammation-mediated progression of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407341      PMCID: PMC2709369          DOI: 10.1074/jbc.M109.003269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch.

Authors:  Y Gu; H Misonou; T Sato; N Dohmae; K Takio; Y Ihara
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

Review 2.  The angiotensin II type 1 receptor and receptor-associated proteins.

Authors:  D F Guo; Y L Sun; P Hamet; T Inagami
Journal:  Cell Res       Date:  2001-09       Impact factor: 25.617

3.  Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration.

Authors:  S Desai; H April; C Nwaneshiudu; B Ashby
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

4.  Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor.

Authors:  S Desai; B Ashby
Journal:  FEBS Lett       Date:  2001-07-20       Impact factor: 4.124

5.  Elevated CSF prostaglandin E2 levels in patients with probable AD.

Authors:  T J Montine; K R Sidell; B C Crews; W R Markesbery; L J Marnett; L J Roberts; J D Morrow
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

6.  Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.

Authors:  L Ho; D Purohit; V Haroutunian; J D Luterman; F Willis; J Naslund; J D Buxbaum; R C Mohs; P S Aisen; G M Pasinetti
Journal:  Arch Neurol       Date:  2001-03

7.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

Authors:  X Lin; G Koelsch; S Wu; D Downs; A Dashti; J Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice.

Authors:  K I Andreasson; A Savonenko; S Vidensky; J J Goellner; Y Zhang; A Shaffer; W E Kaufmann; P F Worley; P Isakson; A L Markowska
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 10.  Proteolytic processing and cell biological functions of the amyloid precursor protein.

Authors:  B De Strooper; W Annaert
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  22 in total

1.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

2.  Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.

Authors:  Nathaniel S Woodling; Qian Wang; Prachi G Priyam; Paul Larkin; Ju Shi; Jenny U Johansson; Irene Zagol-Ikapitte; Olivier Boutaud; Katrin I Andreasson
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 3.  Minireview: Spatial Programming of G Protein-Coupled Receptor Activity: Decoding Signaling in Health and Disease.

Authors:  Camilla West; Aylin C Hanyaloglu
Journal:  Mol Endocrinol       Date:  2015-06-29

4.  Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Authors:  Massimo F L Pomponi; Giovanni Gambassi; Massimiliano Pomponi; Carlo Masullo
Journal:  Aging Dis       Date:  2010-07-12       Impact factor: 6.745

5.  Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Pei-Pei Guan; Yun-Yue Liang; Long-Long Cao; Xin Yu; Pu Wang
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Angiotensin II AT1 receptor blockade ameliorates brain inflammation.

Authors:  Julius Benicky; Enrique Sánchez-Lemus; Masaru Honda; Tao Pang; Martina Orecna; Juan Wang; Yan Leng; De-Maw Chuang; Juan M Saavedra
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

Review 7.  Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease.

Authors:  Hari Manev; Hu Chen; Svetlana Dzitoyeva; Radmila Manev
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-05       Impact factor: 5.067

Review 8.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

9.  Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.

Authors:  Inger Vedin; Tommy Cederholm; Yvonne Freund-Levi; Hans Basun; Erik Hjorth; Gerd Faxén Irving; Maria Eriksdotter-Jönhagen; Marianne Schultzberg; Lars-Olof Wahlund; Jan Palmblad
Journal:  J Lipid Res       Date:  2009-11-24       Impact factor: 5.922

Review 10.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.